MedTrace Logo

Retrospective Analysis for Patients With Metabolic Syndrome

NCT06182618 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-12-27

No results posted yet for this study

Summary

The incidence of metabolic syndrome and related diseases is gradually increasing, and diet and medication are currently common outpatient treatment methods. This study retrospectively analyzes the clinical data of patients with metabolic syndrome and related diseases who have visited our outpatient department in the past 10 years, compares the therapeutic effects of different treatment methods on their blood glucose, blood lipids, blood pressure, uric acid, and body composition, and provides evidence support for clinical treatment.

Conditions

  • Metabolic Syndrome

Interventions

OTHER

dietary, semaglutide or/and metformin

patients were prescribed dietary and pharmaceuticals for weight loss

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06182618 on ClinicalTrials.gov